NephroGenex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
NephroGenex, Inc. had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price of $3.23 per share as of 2015-12-31, per its 10-K filed 2016-03-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice · last filed 2016-03-29
- 2015-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $3.23.
- 2015-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $2.88.
- 2015-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $2.70.
- 2015-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price $2.50.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2015-12-31 | $3.23 10-K · filed 2016-03-29 |
| 2015-09-30 | $2.88 10-Q · filed 2015-11-12 |
| 2015-06-30 | $2.70 10-Q · filed 2015-08-12 |
| 2015-03-31 | $2.50 10-Q · filed 2015-05-13 |
| 2014-12-31 | $2.08 10-K · filed 2015-03-24 |
| 2014-09-30 | $1.80 10-Q · filed 2014-11-12 |
| 2014-06-30 | $1.70 10-Q · filed 2014-08-12 |